AMICUS THERAPEUTICS INC
Industry: Life Sciences ・ $FOLD on Nasdaq
Insider Sale
+$75,000
-0.84%
Shares
Shares Volume: 7,500 Shares
Average Share Price: $10
INSIDER
Campbell Bradley L
President and CEO (Director)
reported on Jun 5 2024
traded on Jun 3 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 886,654 |
| PURCHASES/SALES 1Y | 0 / 15 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $150,080.74 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 46 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $210,500.05 |
| COMPANY PREVIOUS TRADES |